Narrative Review: Obesity, Type 2 DM and Obstructive Sleep Apnoea—Common Bedfellows
Open Access
- 8 August 2022
- journal article
- review article
- Published by MDPI AG in Diabetology
- Vol. 3 (3) , 447-459
Abstract
Obstructive sleep apnoea (OSA) and type 2 DM mellitus (T2DM) share obesity as a major risk factor. Furthermore, these conditions share overlapping mechanisms including inflammation, activation of the autonomic nervous system, and hypoxia-linked endocrinopathy. Hence, the pathogenesis of the two conditions may be more closely related than previously recognised. This raises the question of whether treatment of OSA might assist resolution of obesity and/or T2DM. Here, we present a narrative review of the literature to identify clinical and scientific data on the relationship between obstructive sleep apnoea and T2DM control. We found there is a paucity of adequately powered well-controlled clinical trials to directly test for a causal association. While routine screening of all T2DM patients with polysomnography cannot currently be justified, given the high prevalence of sleep disordered breathing in the overweight/obese population, all T2DM patients should at a minimum have a clinical assessment of potential obstructive sleep apnoea risk as part of their routine clinical care. In particular, screening questionnaires can be used to identify T2DM subjects at higher risk of OSA for consideration of formal polysomnography studies. Due to morbid obesity being a common feature in both T2DM and OSA, polysomnography should be considered as a screening tool in such high-risk individuals.Keywords
This publication has 109 references indexed in Scilit:
- Obstructive Sleep Apnea Is a Predictor of Abnormal Glucose Metabolism in Chronically Sleep Deprived Obese AdultsPLOS ONE, 2013
- Integrative miRNA-mRNA Profiling of Adipose Tissue Unravels Transcriptional Circuits Induced by Sleep FragmentationPLOS ONE, 2012
- Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: A cross-sectional studyCardiovascular Diabetology, 2011
- Protective vascular and myocardial effects of adiponectinNature Clinical Practice Cardiovascular Medicine, 2008
- Sleep-Disordered Breathing and Impaired Glucose Metabolism in Normal-Weight and Overweight/Obese IndividualsDiabetes Care, 2008
- Slow-wave sleep and the risk of type 2 diabetes in humansProceedings of the National Academy of Sciences, 2008
- Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetesThorax, 2007
- Intermittent Hypoxia Causes Insulin Resistance in Lean Mice Independent of Autonomic ActivityAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Adiponectin actions in the cardiovascular systemCardiovascular Research, 2007
- Inflammation and insulin resistanceJournal of Clinical Investigation, 2006